Nasdaq:US$16.01 (-0.78) | HKEX:HK$24.95 (-1.45) | AIM:£2.35 (-0.15)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor